Auxilium (AUXL +0.9%) ticks higher after BofA Merrill Lynch ups its price target on the shares to $28 from $24 on the back of yesterday's positive Phase 3 results of Xiaflex in fighting Peyronie's disease
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/